Ranganath M (@dr_muniyappa) header
Ranganath M (@dr_muniyappa) profile picture

Endocrinologist with an interest in diabetes, obesity, and cardiovascular disease. Views/comments my own. RT🚫 endorsement

Potomac
Joined January 2013
Photo by Ranganath M (@dr_muniyappa)Photo by Ranganath M (@dr_muniyappa)Photo by Ranganath M (@dr_muniyappa)Photo by Ranganath M (@dr_muniyappa)Photo by Ranganath M (@dr_muniyappa)Photo by Ranganath M (@dr_muniyappa)Photo by Ranganath M (@dr_muniyappa)Photo by Ranganath M (@dr_muniyappa)Photo by Ranganath M (@dr_muniyappa)Photo by Ranganath M (@dr_muniyappa)
New content online: Imaging for localizing and therapeutic management of primary aldosteronism: the primary aldosteronism imaging outcome consensus dlvr.​it/TWMwPT
16
50
3,119
Ranganath M retweeted
Elon Musk (2026): “I’m not MAGA…” Elon Musk (2024): “I’m not just MAGA… I’m Dark Gothic MAGA!”
397
3,134
389
15,923
597,703
Ranganath M retweeted
Young people around the world are not okay. Incredible graphs from WSJ 1. Unemployment rates for young college grads have been climbing compared with the broader population for years 2. AI might be exacerbating the employment challenges for young ppl in software 3. In Italy and Spain, more than 80% people in their 20s live with their parents (!?!!?) 4. Youth unemployment in China has gone from non-existent to one of the highest in the world during a period when its poverty rate has plunged. Weird.
72
351
51
1,867
214,076
I had an interesting career, but there's no denying to myself that it was mostly a failure. I also feel it on a very personal level because one of my best friends is homeless & I see first hand how difficult his life is. Wish I could at least help him more, but he's too proud to let me.
Replying to @AllenFrancesMD
This must be heartbreaking.
23
11
6
128
8,538
"I'm not MAGA. I'm not even sure what MAGA means." Years from now, the American people will fully reckon with the damage these oligarchs, have inflicted on our public institutions. The consequences will be felt for generations.
Elon today: "I'm not MAGA. I'm not even sure what MAGA means." This is the guy who spent nearly a billion dollars on the movement, called opposing it an existential threat, and worked inside the Trump administration. Sorry dude, you're not rebranding now.
119
Lilly’s CEO @DaveARicks making the case for broader GLP-1 coverage, backed by a clear cost-benefit analysis. A masterclass in communication. I wish more leaders (govt & pvt), engaged with the public this way, with clarity & substance.
Replying to @ZReitano
The CVS analysis shows these medicines reduce hospital stays 34-42%, ER visits 10-12%, and major heart event odds 14%. That is the news. On price: the $617-766 employer figure is dated. Employers can now get Zepbound KwikPen for $449 a month (less employee out-of-pocket) at every dose; Foundayo is even lower. Medicare and Medicaid pay $245. U.S. realized prices fell 15% in Q3 2025 and another 7% in Q3 2026. Three years is a short window for a chronic disease; modeling shows compounding benefits over time. Greater access in employer insurance markets could cut health costs and deliver broader human and economic gains. We agree with CVS: broaden coverage for Americans.
1
218
This jesticulator-in-chief is also a full-blown 🤡 This country just can't catch a break. We deserve so much better.
“What does ‘ending the war’ mean? Not funding their operations in the Gulf?” @RepJeffries: “Well, no...”
75
The is exactly how my grandfather looked when he said he could find the bathroom himself.
Schumer: I’m confident we’ve got the votes.
2
2
50
4,167
👀
We break: The highly classified network that the National Security Agency uses for its internal communications is down, according to five people familiar with the matter. The network, called NSA Net, allows employees to communicate classified information internally. At this point there is no evidence of a cyberattack, sources said. As the agency works to understand the scope of the problem, it has enacted staggered arrivals for personnel, the sources said. CNN has asked the National Security Agency for comment. cnn.com/2026/11/17/politics/…
71
Ranganath M retweeted
I once needed to see an eye doctor urgently and was told similarly a 1 year wait if not established patient. Like how many potential patients are established?!?! So I called pacific eye and was seen next day. Access should be a quality metric. It would be more meaningful than 95% of quality metrics that exist today. IMO many of best systems would do poorly on this
After trying to schedule an ophthalmology appointment at UCSF I would like to call on all tech bros to move faster and break more things because I tried to envision a dumber user experience and failed. First - do I call “Ucsf [sic] Medical Center/ prof Fees” or the one without “prof Fees”? Next if you are lucky enough to figure out the right number, you get to navigate a phone tree and wait for 10-15 minutes. Next if you are lucky enough to talk to a person you get to supply them with all of your personal and insurance information over the phone because a web form would be too much to ask. And then you get to discover the next appointment is in a year on November 17, 2027. Joke institutions. Doctors and patients deserve better. Give tech the keys to the car and 2x twenty somethings will build a better booking experience. It will last for at least 6 months before Epic shuts it down.
6
2
25
3,972
Ranganath M retweeted
This is a good slide, nicely summarizing what causal models enable us to do, and how little we need to assume to get them to work. Thanks for posting. @ConjectureInst
The Math of Why Conjecture Institute Advisor @yudapearl’s structural causal models turned causation into mathematics: draw the causes, write the mechanisms, intervene with do(X), and ask what would have happened. The math of why, in four steps 👇
4
29
1
189
10,640
Ranganath M retweeted
We're truly honoured and grateful to see our work recognised in this thoughtful commentary. It means a great deal, particularly coming from someone whose contributions to the field I have long admired. Thank you @zenbrainest, for highlighting our work.
Chemogenetics reveals a surprising role for GPR18 signaling in immunometabolic regulation of β cell activity: doi.org/10.1172/JCI212477 Xianglin Huang & Bryan L. Roth provide a Commentary on Singh et al.: doi.org/10.1172/JCI212477 @SimranSingh_26 @saip_pydi #T2D
2
7
31
926
Dear America, Secretary of Homeland Security 🫡
MULLIN ON OUTAGES: I talked to one guy in the tech industry, he asked not to mention his name, it's not Elon. I asked, what could be causing these outages? He said I believe it's SI, because these programs aren't designed to work as fast as SI is.  So when they put in a program that's able to write codes and it goes in and self-fixes, as it starts to self-fix itself it like a change order on a house. That kind of makes sense to me.
90
I take absolutely no pleasure in being 100% right about this. First, JAMA published the misleading corporate propaganda piece claiming AI is better than physicians from authors who are all financially tied to medical AI companies. Now, the FDA has cited that very paper in its new AI roadmap entitled “A Clinical Super Intelligence Roadmap: Better Answers, Faster Care, and Lower Costs.” This is precisely how corporate propaganda seeps into legitimate policy, guiding federal focus and research funding towards venture capital returns and shareholder profit — and away from the public interest. It remains incredibly disappointing, yet entirely predictable, to see one of our most prestigious medical journals in JAMA co-opted to manipulate federal policy in ways that line the pockets of venture capitalists at the expense of patients and the physicians that care for them.
Some people have asked me why I’m making fun of that JAMA viewpoint piece so much. It’s because corporate propaganda is not benign. It influences both public sentiment and government policy. To issue a press release on your company’s website touting biased comparisons as evidence of your product’s efficacy is one thing. To publish what amounts to a corporate advertisement with the imprimatur of a prestigious peer-reviewed journal (albeit under the guise of a “viewpoint” piece) is entirely another — co-opting the legitimizing effects of journal publication to imply that somehow the scientific community has blessed your company’s product. The article in question will no doubt be used by its heavily conflicted authors to garner further investment for their companies and to lobby the government to shape CMS policy in their favor — giving further institutional credence, and potentially public money, to their proprietary technology. The AI hype cycle will continue with its air of inevitability, despite not having objectively demonstrated benefit to anyone apart from corporate shareholders.
6
71
3
338
18,954
Stephen A Smith: "I don’t even know if I should admit this on air, but it’s true. I kinda felt like, “I could be here (in the White House). I could do this (be a President).” Dear lord! mediaite.com/media/news/i-do…
2
184